We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VentriPoint Launches Multicenter Clinical Trial for FDA Submission

News   Sep 22, 2011

 
VentriPoint Launches Multicenter Clinical Trial for FDA Submission
 
 
 

RELATED ARTICLES

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

5.1 Million Dollar Funding Boost for Blinding Retinal Conditions

News

A $5.1 million grant has been awarded from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.

READ MORE

Immunotherapy Success for Triple-Negative Breast Cancer

News

New research has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE